FDA Adverse Event Injury Summary report: N

NEPHROSTOMY CATHETER SETS

MDR report key: 21343140 · Received February 10, 2025

Report

Report Number
2124215-2025-03635
Event Type
Injury
Date Received
February 10, 2025
Date of Event
December 19, 2024
Report Date
February 10, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
GBO
UDI-DI
08714729009733
PMA / PMN Number
K820867
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BLOCK A2: THE PATIENT WAS REPORTED TO BE BETWEEN 71-80 YEARS OLD. BLOCK B3: THE EVENT DATE WAS APPROXIMATED BASED ON THE PROCEDURE DATE. BLOCKS D4, H4: THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER; THEREFORE, THE LOT EXPIRATION AND DEVICE MANUFACTURE DATES ARE UNKNOWN. BLOCK H6: IMDRF PATIENT CODE (B)(6) CAPTURES THE REPORTABLE EVENT OF "BLEEDING REQUIRING INTERVENTION." IMDRF IMPACT CODE F23 CAPTURES THE REPORTABLE EVENT OF "ANGIOEMBOLIZATION WAS PERFORMED FOR RENAL BLEEDING AND OTHER ADDITIONAL INTERVENTION."

Description of Event or Problem · 0

IT WAS REPORTED THAT A NEPHROSTOMY CATHETER SET WAS USED TO ESTABLISH PERCUTANEOUS NEPHROSTOMY ACCESS AND URINE DRAINAGE DURING A PERCUTANEOUS NEPHROSTOMY WITH PERCUTANEOUS NEPHROLITHOTOMY (PCNL) PROCEDURE PERFORMED ON (B)(6) 2024. FOLLOWING HOSPITAL DISCHARGE, THE PATIENT EXPERIENCED BLEEDING DURING THE CATHETER INDWELLING PERIOD, REQUIRING INTERVENTION. ANGIOEMBOLIZATION WAS PERFORMED FOR RENAL BLEEDING, THOUGH DETAILS OF ANY ADDITIONAL INTERVENTION WERE NOT REPORTED. THE CATHETER WAS REMOVED ON (B)(6) 2024, WITH NO SERIOUS ADVERSE EVENTS REPORTED IN CONNECTION TO THIS INCIDENT. PER PHYSICIAN'S ASSESSMENT, THE EVENT WAS NOT RELATED TO THE DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1957676 NEPHROSTOMY CATHETER SETS CATHETER, NEPHROSTOMY, GENERAL & PLASTIC SURGERY GBO BOSTON SCIENTIFIC CORPORATION M0064201110 08714729009733

Patients

Seq Age Sex Outcome Treatment
1 NA Male Other| R